Abstract
Purpose
This study examines the associations between migraine headaches, well-being, and health care use among a sample of underserved older African American adults. Controlling for relevant variables, the association between migraine headaches and (1) health care utilization, (2) health-related quality of life (HRQoL), and (3) physical and mental health outcomes was examined.
Methods
Our sample included 760 older African American adults from South Los Angeles recruited through convenience and snowball sampling. In addition to demographic variables, our survey included validated instruments, such as the SF-12 QoL, Short-Form McGill Pain Questionnaire, and the Geriatric Depression Scale. Data analysis included 12 independent multivariate models using multiple linear regression, log transferred linear regression, binary and multinomial logistic regression, and generalized linear regression with Poisson distribution.
Results
Having migraine was associated with three categories of outcomes: (1) higher level of health care utilization measured by (i) emergency department admissions and (ii) number of medication use; (2) lower level of HRQoL and health status measured by (i) lower self-rated health (ii) physical QoL, and (iii) mental QoL; and (3) worse physical and mental health outcomes measured by (i) higher number of depressive symptoms, (ii) higher level of pain, (iii) sleep disorder, and (iv) being disabled.
Conclusions
Migraine headache significantly was associated with quality of life, health care utilization, and many health outcomes of underserved African American middle-aged and older adults. Diagnoses and treatments of migraine among underserved older African American adults require multi-faceted and culturally sensitive interventional studies.
Keywords: Ethnic groups, Migraine, Headache, Quality of life, Morbidity, Chronic disease
Introduction
Migraine headache is a common disorder characterized by recurrent, pulsating moderate to severe headaches with associated nausea, photophobia, and phonophobia [1]. Migraineurs may experience an aura prior to the onset of headache, commonly involving vision or sensory disturbances. It ranks among the top ten causes of disability worldwide and appears to be more prevalent among individuals of lower socioeconomic status [2]. Migraine accounts for approximately 1.5% of primary care visits annually.
The burden of self-reported migraine and severe headache in the US adult affects roughly 1 out of 6 Americans [3]. In 2018, the age-adjusted prevalence was close to 16% across all adults. Approximately 20% of women and 10% of men are affected [4]. Migraine carries a considerable physical, social, and economic burden [5]. Although the prevalence of migraine tends to decrease between 50 and 60 years of age, a significant number of older adults continue to experience migraine or have new-onset migraine [6]. The diagnosis of migraine in older adults may be more challenging and treatment options may be limited due to the presence of comorbid medical conditions [7, 8]. The clinical phenotype of migraine differs in the older adult patient group (compared to that of younger adults), with older adult migraine often occurring bilaterally, affecting the neck, presenting without pain, presenting with vegetative symptoms (i.e., loss of energy, anorexia) and being associated with “late-life migraine accompaniments,” referring to focal neurologic symptoms similar to that of an aura or transient ischemic attack [9, 10]. Given the decreasing prevalence of migraine with age, increased presence of risk factors for cerebrovascular disease, and the increased incidence of secondary headache conditions, older adult patients presenting with new-onset migraines may be subjected to additional diagnostic testing, such as neuroimaging, to rule out conditions such as cerebral infarction, transient ischemic attack, or hemorrhage.
Migraine has been noted to be comorbid with a number of conditions, including mental health disorders (depression, anxiety), cardiovascular disease, sleep disorders, and other neurological conditions, such as Alzheimer’s disease [11–14]. The prevalence of migraine within specific age strata in the USA were as follows: 19.4% (18–24 years), 19.0% (25–44 year), 19.4% (45–54 years), 14.0% (55–64), 9.5% (65–74 years), and 6.1% (> 75 years) [15]. However, there are limited epidemiological data about headache in elderly persons in the USA, especially those from minority backgrounds [16].
Examination of data collected by the National Health Interview Survey revealed that 15.5% of Whites and 14.45% of African Americans suffer from severe headache or migraine [17]. Migraine remains underdiagnosed and associated with worse outcomes among those of under-represented backgrounds and those who are underinsured or uninsured [18]. The American Migraine Prevalence and Prevention Study reported that migraine prevalence increased as lower household income decreased both for male and females [19]. While one study documented that migraine health care utilization, diagnosis, and treatment were low for African Americans, especially, for those who reported lower levels of trust and communication with doctors relative to Caucasians [20]. Another study found no major racial/ethnic differences in abortive or prophylactic treatment [21]. Indeed, reviewing current literature, Befus and colleagues in 2018 documented that African Americans were less likely to seek medical care and may not be receiving adequate care in comparison with their Caucasian counterparts [22].
Another extensive review of literature by Klenofsky and Shabas in 2019 showed that even though migraine is slightly less common in African Americans than Caucasians, African Americans are more likely to experience debilitating migraine headaches [23]. This study shows that African Americans have more frequent and severe migraines and the condition is more likely to become chronic [23]. Therefore, race-related disparities prevent African American migraine patients from accessing available treatments [24]. A recent study conducted by Amico and colleagues (2022) that included 61,453 hospitalized migraine patients revealed that African American, Hispanic, or Native American patients were more likely to have lower household income (p < 0.001), whereas Caucasian patients had a higher income [25]. However, studies on race-related gaps and possible healthcare inequalities in people with headache disorders are virtually non-existent [26]. Understanding potential race-related disparities in migraine patients may inform the development of culturally contextualized health care policies and interventions that are more likely to reduce or eradicate race-related headache disparities [24].
A health equity approach to migraine research and treatment requires examining underlying, intersecting social and structural factors as well as biological and behavioral contributions [22]. Therefore, continued research regarding disparities in migraine headache medicine is urgently needed [27]. This study examines correlates of migraine headaches among a sample of underserved older African American adults. Controlling for age, gender, education, marital status, satisfaction with and access to medical care, and number of major chronic conditions, the association between migraine and the following outcome variables are examined: (1) health care utilization; (2) health-related quality of life (HRQoL) and self-rated of health; and (3) physical and mental health outcomes.
Methods
Study Population
We recruited 760 adults from senior housing centers, senior centers, faith-based organizations, and apartment complexes in the South Los Angeles community. We included participants who self-identified as African American aged 55 years or older and committed to remaining in the area for the next year. Recruitment was completed during regular office hours, usually in the dining or day room areas. The Service Planning Area 6 (SPA6) of Los Angeles (LA) County is home to over one million residents. This area of LA County is disproportionately burdened by health disparities compared to all of Los Angeles County [28]. A good example is the hospitalization rate for heart failure, which is significantly higher for SPA6 compared to the rest of Los Angeles county (rate700/100,000 for South LA versus 350/100,000 LA County). It is disparities such as these that are tied to the objectives of this project. All the participants provided signed informed consent. Charles R. Drew University of Medicine and Science’s Institutional Review Board (IRB) approved the study protocol.
Measurements
Survey Instruments
Along with standard items that measure demographic variables, our survey included validated instruments to document HRQoL [29], self-rated health status and health care access, the Short-Form McGill Pain Questionnaire-2 (SF-MPQ-2) [30, 31], and Geriatric Depression Scale (GDS) [32, 33].
Demographics Characteristics
Age, gender, educational attainment, marital status, and race/ethnicity were the demographic covariates in this study. We operationalized education attainment as the number of years of school attendance with higher values indicating more years of education. Marital status was categorized as a dichotomous variable: married or living with a partner (yes/no).
Financial Strain
Five items were used to measure financial strain. Participants were asked about the frequency of their inability to perform the following actions in the last 12 months: (1) purchasing enough food for their family, (2) buying clothes they deemed necessary, (3) paying rent or mortgage, (4) paying monthly bills, and (5) making ends meet. Responses were recorded on a 5-point scale, with options ranging from 1 (never) to 5 (always). We computed a total score for “financial strain” by averaging the responses across the five items, with scores ranging from 1 to 5. Higher scores indicated greater financial difficulty. These items are in line with Pearlin’s list of chronic financial challenges faced by low SES individuals and showed high internal consistency (Cronbach alpha = 0.92) [34].
Satisfaction with and Access to Medical Care
Six items were used to measure this variable. Participants were asked (1) In the last 12 months have you needed to see a doctor but could not see one? (2) Overall, how difficult is it for you to get medical care? (3) How difficult would it be for you to get a routine physical exam? (4) How difficult is it for you to visit a doctor when you need medical care? And (5) overall, how satisfied are you with how available medical care is for you? And (6) overall, how satisfied are you with how available medical care is for you? Using principal component analysis, primary factors underlying this 6-item instrument were identified. Varimax rotation produced two distinct factors, explaining almost 63 of the variance. The first factor explained 36% of the variance while the second factor explained 27% of the variance. All items had primary loadings over 0.5, and none of the items had a cross-loading above 0.24. The first factor was associated with the 3 items that measured perceived difficulty accessing medical care and the second factor was associated with three items that measured satisfaction with care.
Disability Status
Disability status was assessed as a dichotomous variable with a single item asking participants whether s/he is disabled (yes/no).
Health Care Utilization
Participants were asked (1) how many times they had utilized Emergency Department (ED), (2) stayed overnight at a hospital as a patient, or (3) visited a provider at their office in the last 12 months.
Major Chronic Conditions
Participants reported whether they had been diagnosed with the following medical conditions: high blood pressure, diabetes mellitus, heart-related conditions, cancer, stroke, chronic obstructive pulmonary disease (COPD), or a sleep disorder.
Self-Rated Health Status
This variable was measured by the question: “In general, would you say your health is (1) excellent; (2) very good; (3) good; (4) fair; and (5) poor?” Because self-rated health is differently shaped by social determinants across ethnic groups, this item is often used in national surveys and predicts mortality risk in ethnic groups.
Pain Severity
Pain was measured using the Short-Form McGill Pain Questionnaire-2 (SF-MPQ-2) [30, 31]. Participants self-reported the level to which they experienced each of four subscales derived from 22 pain items experienced in the past week. The form uses an 11-point numeric rating scale. Psychometric properties of the SF-MPQ-2 among non-Hispanic and Hispanic White patients with pain show that this measure is comparable across these 2 ethnic groups [35].
Health-Related Quality of Life (SF-12)
The SF-12 health survey measures include two subscales that provide an indication of physical and mental functioning and global health-related quality of life [29]. The SF-12 is a multipurpose, 12-item selected from the SF-36 Health Survey [36]. The SF-12 is a validated measure for assessing health status among low-income minority populations [37]. We computed physical and mental health composite scores (PCS & MCS) using scores of the twelve questions. The composite scores range from 0 to 100, where a zero score implies the lowest level and 100 indicates the highest level of health. PCS and MCS scores tend to vary over the life span for different age groups: PCS tends to decrease with age, while MCS tends to increase. The mean difference score specific to an individual’s age reflects the deviation of their score from the average score of their age group. If an individual scores higher than the mean, it suggests better health status compared to most others in the same age group. On the other hand, scores lower than the mean suggest poorer health status compared to most others in the same age group [38].
Depressive Symptoms
Depression was evaluated using the 15-item short Geriatric Depression Scale (GDS) [32, 33]. Responses were on a binary yes/no scale. The total score was computed by summing up the responses, yielding a possible range of 0 to 15, where higher scores indicated more severe depressive symptoms. The GDS-Short form has been widely adopted in both clinical and community contexts for measuring depression among older adults due to its excellent reliability and validity [32, 33].
Medication Use
We examined all medications by the drug inventory method. Participants were asked to bring all over-the-counter and prescribed medications that they had taken within two weeks prior to the interviews. The interviewer transcribed from the container label the name of the medication, providers’ information, expiration date, strength of the drug, instructions, special warnings, etc. The medication assessment of this study employed the methodology established by Sorensen and colleagues [39–41], and has been adopted by our research team previously [42–47].
Migraine Headache
Migraine was measured using self-reported data. They were asked, “have you ever been diagnosed with migraines by a health care provider?” Responses were yes and no.
Data Analysis
Our analysis was divided into three parts. The first part was a descriptive analysis of all participants, reported as means and standard deviation for continuous measures and frequency and percentages for the categorical variables. Second, we conducted chi-square test, independent t-test, and ANOVA to examine the bivariate association between socio-demographic variables, and a few other relevant variables and migraine. Finally, we used multivariate generalized linear models (GLM) with Poisson distribution and log link; multiple linear regression; and multiple logistic regression to examine the independent association of migraine on various outcomes. Controlling for age, gender, education, marital status, type of insurance, satisfaction with and access to medical care, and the number of major chronic conditions, association between migraine, and several outcome variables were examined. For GLM and logistic regression, Odds Ratio (OR) and 95% confidence intervals are reported. For linear regression, standardized beta coefficients are reported. For multivariate analysis, p-values of less than 0.05 were considered significant. The Bonferroni correction methods were used to counteract the problem of multiple comparisons at the bivariate association.
Results
Univariate Analysis
Table 1 reports the characteristics of the study sample. This study included 740 African American individuals who were between the ages of 55 and 95 years (mean = 71.73 ± 8.37). Approximately 35% of participants were 75 years of age or older, with only 15% self-reported being married. One out of four participants never completed high school. Regarding health status, we noted the following health conditions/illnesses: diabetes mellitus (35%), hypertension (89%), heart-related conditions (30%), and COPD (26%).
Table 1.
Characteristic of sample and bivariate association between migraine headache and other related outcomes (n = 740)
Sample characteristics | Total sample | Migraine headache | Sig | |
---|---|---|---|---|
No | Yes | |||
N (%) Mean ± SD |
N (%) Mean ± SD |
N (%) Mean ± SD |
||
Gender | 0.021 | |||
Male | 266 (36) | 226 (85) | 40 (15) | |
Female | 472 (64) | 371 (79) | 101 (21) | |
Age | 0.002 | |||
55–64 | 120 (16) | 80 (67) | 40 (33) | |
65–74 | 359 (49) | 302 (84) | 57 (16) | |
75 and older | 260 (35) | 214 (83) | 44 (17) | |
Education | 0.084 | |||
No high school diploma | 183 (25) | 143 (79) | 39 (21) | |
High school diploma | 265 (36) | 207 (78) | 58 (22) | |
Some college/graduate | 292 (39) | 247 (85) | 44 (15) | |
Married/partner | 0.113 | |||
No | 627 (85) | 505 (81) | 121 (19) | |
Yes | 113 (15) | 92 (82) | 20 (18) | |
Disability status | 0.087 | |||
No | 473 (64) | 406 (86) | 65 (14) | |
Yes | 267 (36) | 191 (71) | 76 (29) | |
Sleep disorder | 0.000 | |||
No | 541 (73) | 462 (85) | 79 (15) | |
Yes | 197 (27) | 135 (69) | 62 (31) | |
Mean ± SD | Mean ± SD | Mean ± SD | Sig. | |
Financial strains (rarely: 1 – always: 5) | 1.83 ± 1.23 | 1.74 ± 1.07 | 2.24 ± 1.28 | 0.000 |
Physical health quality of life | 40.26 ± 12.23 | 41.60 ± 12.06 | 34.51 ± 11.34 | 0.000 |
Mental health quality of life | 52.28 ± 10.92 | 53.22 ± 10.13 | 48.37 ± 13.16 | 0.000 |
Self-rated health | 3.13 ± 1.02 | 3.05 ± 1.00 | 3.48 ± 1.01 | 0.000 |
Severity of pain | 2.05 ± 2.25 | 1.72 ± 2.02 | 3.47 ± 2.62 | 0.000 |
Major chronic conditions (0–6) | 2.11 ± 1.10 | 2.07 ± 1.08 | 2.31 ± 1.15 | 0.019 |
Depressive symptoms | 2.47 ± 2.77 | 2.10 ± 2.46 | 4.06 ± 3.44 | 0.000 |
Number of office-based provider visits | 5.51 ± 3.27 | 5.48 ± 3.29 | 5.67 ± 3.20 | 0.543 |
Number of ED admissions | 0.79 ± 1.58 | 0.69 ± 1.39 | 1.22 ± 2.18 | 0.000 |
Number of hospital admissions | 0.54 ± 1.33 | 0.54 ± 1.40 | 0.54 ± 0.99 | 0.984 |
Number of Rx used | 5.87 ± 3.24 | 5.68 ± 3.22 | 6.67 ± 3.23 | 0.002 |
Number of OTC used | 1.18 ± 1.93 | 1.19 ± 1.86 | 1.14 ± 2.19 | 0.797 |
Bivariate Analysis
Table 1 also shows bivariate correlations between migraine and other related variables based on the chi-square, t-test, and ANOVA F-test. Women, young-old, disabled participants, those with higher level of financial strain reported more migraine than their counterparts. In addition, association between reporting migraine and following variables were detected: lower level of HRQoL, higher number of depressive symptoms, sleep disorder, higher number of Rx medication use, higher number of ED admissions, and lower level of self-reported health status. No association between, migraine and office-based provider visits, hospital admissions, OTC use, marital status, or education was detected.
Multivariate Analysis
Table 2 contains the condensed results of 12 independent multivariate analyses. Each analysis controlled for age, gender, education, marital status, financial strain, insurance type (Medicare and Medi-Cal), satisfaction with and access to medical care, and the number of major chronic conditions while examining the independent association between migraine and 12 outcome variables. Having migraine was associated with three categories of outcomes: (1) higher level of health care utilization measured by (i) ED admissions, and (ii) number of medication use; (2) lower level of HRQoL and health status measured by (i) lower self-rated health, (ii) physical QoL, and (iii) mental QoL; and (3) worse physical and mental health outcomes measured by (i) higher number of depressive symptoms, (ii) higher level of pain, (iii) sleep disorder, and (iv) being disabled.
Table 2.
Multivariate analysis of association between migraine headache and outcome variables among underserved older African American adults. Adjusted for age, gender, education, financial strains, access and satisfaction with care, and number of chronic conditions (N = 740)
Dependent/outcome variable | Model | Independent variable: migraine headache (No vs Yes) | |||||
---|---|---|---|---|---|---|---|
B | Beta | 95% CI unstandardized coefficients | Exp. (B) OR | 95% CI Exp. (B) OR |
Sig. | ||
Health care utilization | |||||||
Physician visits | MLR | −.113 | −.014 | −.718–.492 | - | - | .714 |
ED admissions | GLM-P | .357 | - | - | 1.429 | 1.182–1.728 | .000 |
Hospital admissions | GLM-P | −.176 | - | - | .839 | .647–1.088 | .185 |
Number of Rx used | MLR | .687 | .083 | .127–1.247 | .016 | ||
Number of OTC used | GLM-P | .060 | - | - | 1.062 | .886–1.274 | .516 |
Quality of life and perceived health | |||||||
Physical health quality of life | MLR | −4.225 | −.135 | −6.321–−2.128 | - | - | .000 |
Mental health quality of life | MLR | −3.053 | −.110 | −4.979–−1.127 | - | - | .002 |
Self-rated health | MLR | .249 | .096 | .068–.430 | - | - | .007 |
Health outcomes | |||||||
Depressive Symptoms | MLR | 1.297 | .183 | .842–1.751 | - | - | .000 |
Severity of pain | LT-SLR | .377 | .215 | .262–.493 | - | - | .000 |
Sleep disorder | .001 | ||||||
No | BLR | .704 | - | - | 1.00 | Ref | |
Yes | 2.021 | 1.336–3.057 | |||||
Disability status | .003 | ||||||
No | BLR | .639 | - | - | 1.00 | Ref | |
Yes | 1.895 | 1.241–2.893 |
MLR multinomial logistic regression, GLM-P generalized linear regression with Poisson distribution, LT-SLR log transferred linear regression, BLR binary logistic regression
Discussion
Of the older African American adults who participated in our study, more than 21.4% of women and 15% of men (55 years and older) reported migraine headaches. We searched NHANES, BRFSS, and CHIS datasets and found the prevalence of migraine headaches only in NHANES 1999–2004 for adults by race and age. The prevalence of migraines for White men and women were 8.0% and 14.3% and for Black men and women (for the same age group) were 11.7% and 16.4%, respectively. Our findings show a much higher prevalence of migraine in our sample of underserved African Americans aged 55 years and older compared with the NHANES data for the same age group of White and Black women and men. Our survey and the NHANES used a similar item to measure self-report of migraine. The NHANES survey asked “During the past 12 months, did you have severe headaches or migraines?” whereas, our survey asked “Have you ever been diagnosed with migraines by a health care provider?” [48].
Migraine and Health Care Utilization
Our findings indicate that older African American adults who suffer from migraine headaches utilized health care services more often than non-migraineurs, reflecting the contribution of comorbidities and help-seeking behavior. Our study shows that 54% of African Americans 55 years and older who suffered from migraines used ED services at least once within the past 12 months prior to the interview. Indeed, those who reported being diagnosed with migraine had 100% increased odds of using ED services compared with their counterparts with no migraine. Examination of 11 years of data from the National Ambulatory Medical Care Survey showed that the uninsured, and those with Medicaid, receive substandard therapy for migraine, mostly because they received more care in EDs and less in physicians’ offices [49]. This is demonstrated in our results, as there was no increase in care received in physician offices among migraine patients compared to non-migraine patients. To review the scope of the challenges that vulnerable populations are facing, Charleston and colleagues in 2018 argued that underrepresented minority patients encounter numerous healthcare barriers, including lack of access, insurance coverage of treatment, transportation to and from appointments, and prohibitive costs [18]. A recent study conducted by Sheikh and colleagues in 2020 examining predictive factors for pain-related ED returns in middle-aged and older adults, revealed that African Americans who return to the ED for pain have low health literacy [50].
An extensive review of the literature shows that migraine patients do not get the appropriate recommended migraine-specific medications in the ED and instead receive opioids, which have greater risks of abuse and addiction [51]. This could be increasingly the case in older adults whose nephrogenic and/or cardiovascular comorbidities, such as chronic kidney disease and coronary artery disease, limit their ability to receive medications such as triptans, ergot derivatives, and/or ketorolac, which are commonly used as abortive therapeutics for migraine in the ED. Another recent scoping review of literature by Lim and colleagues (2021) reported almost 90% of studies commenting on adherence to hospital or evidence-based guidelines stated that treatment practices for migraine in the ED are varied and stray from established guidelines [52]. In addition, there is empirical data indicating that ED visits commonly result from an inability to access care elsewhere or missed opportunities for diagnosis and treatment [53]. Using the New York City Department of Health and Mental Hygiene Syndromic Surveillance database, Minen and colleagues(2018) conducted a retrospective nested cohort study from 18 NYC EDs and documented that more than 25% of individuals who make an initial ED visit for migraine pain will return to the ED within the next 6 months for another migraine-related visit [54]. Improving migraine-related care for underserved minority older adults in the ED in underserved communities requires coordinated efforts on the part of emergency medical providers, primary care providers, and public health practitioners to address factors related to the overuse of ED services by older minority adults. Challenges and barriers that affect underserved older African American adults with migraine cannot be fully addressed in an over-crowded ED.
Our data further showed that there was no significant increase in hospital admissions among older African American adults with migraines in the past 12 months that the interview occurred. This was an expected finding. While a debilitating and disabling condition, migraine pain rarely requires hospital admission and inpatient care except in the case of intractable vomiting and medication over-use due to treatment with opioids and/or barbiturates [55, 56].
There was no significant difference in the number of office-based provider visits among study participants with migraine compared to non-migraineurs. This finding may coincide with the similar number of major chronic health conditions among non-migraineurs and migraineurs that participated (2.01 and 2.37 respectively). Approximately 70% of patients with migraine that are followed by a clinician for their headache disorder are treated by primary care providers, with the remainder of patients seen by a neurologist or pain specialist [57]. Given that the vast majority of migraine patients see their primary care provider, the patient may elect to discuss migraine-related concerns at annual visits or other pre-planned follow-up visits rather than migraine-specific appointments.
Migraine and Medication Use
Our results demonstrate a strong association between migraine and the use of prescription medications. The number of over-the-counter medications was similar between those with migraine and non-migraineurs (1.14 and 1.19, respectively). However, migraine sufferers used six prescription medications compared to five prescriptions among non-migraineurs.
The options for abortive and preventive migraine therapeutic options are expansive and drug choice is often dependent on the comorbidities of the patient and concurrent pharmacotherapy use. Available medication options become further constricted in older adults as the incidence of comorbidities and potential for drug interactions rise, particularly for abortive medications where the risk of gastrointestinal, cardiovascular, and renal side effects is more prevalent [58]. The American Headache Society recommends optimizing migraine drug selection with consideration to comorbidities and concurrent medication usage [58]. Unfortunately, older adults are frequently excluded from new drug trials for novel migraine preventive medications, such as the calcitonin gene-related peptide monoclonal antibodies, which means safety data is often limited.
Over-the-counter migraine medications are primarily limited to abortive treatment for mild-to-moderate headache pain, such as acetaminophen-aspirin-caffeine combinations and non-steroidal anti-inflammatory drugs. Older patients with coexisting chronic kidney disease, gastrointestinal bleeding, and/or liver disease may not be the best candidates for frequent or repetitive use of these medications and may instead seek out their primary care provider or headache specialist for a prescription medication for preventive headache control or abortive relief [59, 60]. Alternatively, a migraineur may elect to utilize ED services in the event of a moderate-to-severe migraine, especially one who may not have a consistent patient-provider relationship.
Migraine and Health-related Quality of Life
Our data revealed a strong association between migraine and low scores on the SF-12 Health Survey measuring mental health and physical health quality of life compared to other persons of the same age, with an average score of 35.51 and 48.37 out of 100 for physical and mental quality of life, respectively. Older African American adults with migraine who participated in our study also demonstrated poorer self-rated health status responses compared to participants who did not have migraine. A review of the literature revealed scarce studies on the effect of migraine on quality of life among minority older adults, yet numerous reporting the effect of various therapeutic interventions on quality of life in adults with migraines, including those investigating novel treatments and treatments considered alternative.
It is well known that migraine causes significant disability. The impact is not isolated to the pain during the headache attack but includes the associated disablement due to loss of function, failed treatment attempts, and reduced productivity. Patients with migraine may experience increased stress, absenteeism, reduced ability to participate in social activities, and increased costs accrued from health care visits and prescriptions compared to those who do not have migraine [61]. The negative impacts of migraine should be considered given its pathophysiological contribution to the development of comorbid conditions associated with migraine and the psychosocial influence on the patient [61].
Migraine and Depression
After adjusting for other relevant variables, our study showed an association between migraine and depression. Older African American adults with migraines in this study had higher scores on the geriatric depression scale, providing affirmative responses to an average of four GDS items. The association between migraine and the development of depression is well known [62]. This connection may be related to hypothalamic-pituitary-adrenal axis activation leading to a decline in serotonin during migraine headache. Specifically, in older adults, pain is a significant risk factor for the development of depressive mood [63]. The national Health and Retirement Study demonstrated two key findings in congruence with our study: (1) chronic pain is closely associated with the development of depressive symptoms, and (2) African Americans adults have greater pain-related disability than other adults with chronic pain [64]. This is particularly relevant given the high SF-MPQ-2 and GDS scores among our patients with migraines.
Migraine and Sleep Disorder
Our data revealed a strong association between migraine and sleep disorders. There are few studies examining the presence of sleep disorders in older adult patients with migraine headaches, with no studies specifically looking at minority populations with migraine. These studies in older populations have noted the positive association between migraine and poor sleep [65]. Prior cohort studies have demonstrated an increased prevalence of restless leg syndrome (RLS) and poor sleep quality among migraine patients [62]. The sleep association does not end at RLS, however, as numerous other sleep disorders and parasomnias have been implicated, including insomnia [66]. Additionally, obstructive sleep apnea (OSA) and other sleep-disordered breathing have been found to be risk factors for the development of chronic daily headache [67]. In addition to comorbid disorders, sleep is frequently compromised and implicated with the migraine itself; with sleep deprivation often listed as a trigger for a migraine attack and sleep impairment often listed as a consequence of ongoing migraine pain [66].
Migraine and Disability
When adjusting for age, gender, education, financial strain, healthcare access and satisfaction, and number of chronic health conditions, there was a significant association between disability status and migraine headache in our participants. Migraine is one of the leading causes of disability in the USA and the world [68]. Headache disorders, including migraine, have been ranked 14th worldwide among causes of disability-adjusted life years and 2nd worldwide for all ages and sex among causes of years lived with disability. While the worldwide analysis of disability-adjusted life years and years lived with disability were attributed to general headache disorders, 88.2% were attributed to migraine [69].
Strengths and Limitations
The limitations of this study include the non-random convenient sample and cross-sectional design of the study, which limits its generalizability. Because of the cross-sectional design of our study, we cannot make any causal inferences. Second, we did not have access to objective medical histories and records for the participants; therefore, we relied on self-report of chronic conditions. For example, the assumption is made that participants brought in all of the medication vials that they used within 2 weeks prior to the interviews. Lack of access to participants’ medical or pharmacy records limits our ability to validate this assumption and isolate whether participants were prescribed any medication for migraine or whether emergency department visits were for treatment of migraine headache. Despite these limitations, this study and its findings provide valuable insight into the prevalence of migraine headache in older African American adults, associated health care utilization, and health–related outcomes. These results can represent an inflection point for future research addressing health care disparities related to migraine.
Implications
This study documented a much higher prevalence of migraine headache in older African American adults than other national data of the same age group, which speaks to a greater health disparity among migraine than previously thought. Migraine headache significantly correlates with the quality of life, healthcare utilization, and many health outcomes among underserved African American middle-aged and older adults. After adjusting for other relevant variables, our study showed that there was an association between migraine and depression as well as sleep disorders. Similarly, this study documented a significant association between disability status and migraine headache. Our results also demonstrated a strong association between migraine and the use of prescription medications.
Given our study results, the high prevalence of migraine in this population and the association of migraine with disability, healthcare utilization, and comorbidities, there is increased suffering related to migraine headache among underserved African American older adults that extends far beyond the headache pain itself, as evidenced by reduced quality of life, disability status, and depression. Migraine headache is often thought of as a condition of young adults; our study brings awareness to the diagnosis and burden of migraine specifically in underserved African American older adults.
Migraine is a chronic condition requiring solutions targeted at chronic disease management. Health care providers working in underserved areas need to be aware of the diagnosis within this population and be cognizant of appropriate treatment options to manage headache within this population based on comorbidities to reduce disability associated with the disease and utilization of emergency medicine services. Specialists are often not needed to make the diagnosis of migraine and in under–resourced communities, waiting to get in with a specialist can significantly delay the diagnosis and initiation of treatment.
Diagnoses and treatments of migraine among underserved older African American adults require multi-faceted and culturally sensitive interventional studies. Further studies assessing the prevalence of migraine in older African American adults would be beneficial in addressing the true impact of migraine in this population.
Author Contribution
MB was involved in the conception and design of the study as well as conducting the data analysis and interpretation. JG, LK, SA, and MB together drafted the initial manuscript. All authors reviewed the manuscript critically for intellectual content and approved the submitted version.
Funding
Open access funding provided by SCELC, Statewide California Electronic Library Consortium This study was supported by the Centers for Medicare and Medicaid Services (CMS) grant 1H0CMS331621 to Charles R. Drew University of Medicine and Science (PI: M. Bazargan). Additionally, Drs. Cobb and Kibe were supported by the National Institutes of Health (NIMHD) under awards R25 MD007610 (PI: M. Bazargan).
Code Availability
N/A.
Declarations
Ethics Approval
Ethical approval for the study was obtained from the Institutional Review Committee of the CDU. Participants provided informed consent. The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees. IRB Approval Number [1489890-5]
Consent to Participate
All adults who participated in this study were given information about the study including potential risk and benefits. Consent form significantly described the purpose of the study. Ample opportunity was allowed for participants and their family members to ask questions and to discuss what it meant. All participants signed the consent forms. Illiterate participants provided consent in the presence of a reliable or legally authorized family member.
Consent for Publication
The consent form explained that those who participated also gave their consent to utilize the information in a non-identified format for scientific and popular publications.
Conflict of Interest
The authors declare no competing interests.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Arnold M. Headache classification committee of the international headache society (IHS) the international classification of headache disorders. Cephalalgia. 2018;38(1):1–211. doi: 10.1177/0333102417738202. [DOI] [PubMed] [Google Scholar]
- 2.Frese T, Druckrey H, Sandholzer H. Headache in general practice: frequency, management, and results of encounter. Int Sch Res Notices. 2014;2014. [DOI] [PMC free article] [PubMed]
- 3.Burch R, Rizzoli P, Loder E. The prevalence and impact of migraine and severe headache in the United States: figures and trends from government health studies. Headache. 2018;58(4):496–505. doi: 10.1111/head.13281. [DOI] [PubMed] [Google Scholar]
- 4.Burch R, Rizzoli P, Loder E. The prevalence and impact of migraine and severe headache in the United States: updated age, sex, and socioeconomic-specific estimates from government health surveys. Headache. 2021;61(1):60–68. doi: 10.1111/head.14024. [DOI] [PubMed] [Google Scholar]
- 5.Elgendy IY, Nadeau SE, Bairey Merz CN, Pepine CJ. Migraine headache: an under-appreciated risk factor for cardiovascular disease in women. J Am Heart Assoc. 2019;8(22):e014546. doi: 10.1161/JAHA.119.014546. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Soni PP, Lee M, Shadbehr N, Ahmed ZA. Recent advances in the management of migraine in older patients. Drugs Aging. 2020;37(7):463–468. doi: 10.1007/s40266-020-00776-9. [DOI] [PubMed] [Google Scholar]
- 7.Starling AJ. Diagnosis and management of headache in older adults. Mayo Clin Proc. 2018;93(2):252–62. 10.1016/j.mayocp.2017.12.002. [DOI] [PubMed]
- 8.Riggins N, Ehrlich A. Episodic migraine and older adults. Curr Pain Headache Rep. 2022;26:331–335. doi: 10.1007/s11916-022-01029-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Wijeratne T, Tang HM, Crewther D, Crewther S. Prevalence of migraine in the elderly: a narrated review. Neuroepidemiology. 2019;52(1-2):104–110. doi: 10.1159/000494758. [DOI] [PubMed] [Google Scholar]
- 10.Martins KM, Bordini CA, Bigal ME, Speciali JG. Migraine in the elderly: a comparison with migraine in young adults. Headache. 2006;46(2):312–316. doi: 10.1111/j.1526-4610.2006.00343.x. [DOI] [PubMed] [Google Scholar]
- 11.Morton RE, St John PD, Tyas SL. Migraine and the risk of all-cause dementia, Alzheimer’s disease, and vascular dementia: a prospective cohort study in community-dwelling older adults. Int J Geriatr Psychiatry. 2019;34(11):1667–1676. doi: 10.1002/gps.5180. [DOI] [PubMed] [Google Scholar]
- 12.Scher AI, Bigal ME, Lipton RB. Comorbidity of migraine. Curr Opin Neurol. 2005;18(3):305–310. doi: 10.1097/01.wco.0000169750.52406.a2. [DOI] [PubMed] [Google Scholar]
- 13.Monteith TS, Gardener H, Rundek T, Elkind MS, Sacco RL. Migraine and risk of stroke in older adults: Northern Manhattan Study. Neurology. 2015;85(8):715–721. doi: 10.1212/WNL.0000000000001854. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Szok D, Csáti A, Vécsei L, Tajti J. Chronic migraine as a primary chronic pain syndrome and recommended prophylactic therapeutic options: a literature review. Life. 2023;13(3):665. doi: 10.3390/life13030665. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Smitherman TA, Burch R, Sheikh H, Loder E. The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache. 2013;53(3):427–436. doi: 10.1111/head.12074. [DOI] [PubMed] [Google Scholar]
- 16.Cohen CI, Henry KA. The prevalence of headache and associated psychosocial factors in an urban biracial sample of older adults. Int J Psychiatry Med. 2011;41(4):329–342. doi: 10.2190/PM.41.4.c. [DOI] [PubMed] [Google Scholar]
- 17.Loder S, Sheikh HU, Loder E. The prevalence, burden, and treatment of severe, frequent, and migraine headaches in US minority populations: statistics from National Survey studies. Headache. 2015;55(2):214–228. doi: 10.1111/head.12506. [DOI] [PubMed] [Google Scholar]
- 18.Charleston L, IV, Royce J, Monteith TS, Broner SW, O'Brien HL, Manrriquez SL, Robbins MS. Migraine care challenges and strategies in US uninsured and underinsured adults: a narrative review, part 1. Headache. 2018;58(4):506–511. doi: 10.1111/head.13286. [DOI] [PubMed] [Google Scholar]
- 19.Stewart WF, Roy J, Lipton RB. Migraine prevalence, socioeconomic status, and social causation. Neurology. 2013;81(11):948–955. doi: 10.1212/WNL.0b013e3182a43b32. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Nicholson RA, Rooney M, Vo K, O'Laughlin E, Gordon M. Migraine care among different ethnicities: do disparities exist? Headache. 2006;46(5):754–765. doi: 10.1111/j.1526-4610.2006.00453.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Charleston L, IV, Burke JF. Do racial/ethnic disparities exist in recommended migraine treatments in US ambulatory care? Cephalalgia. 2018;38(5):876–882. doi: 10.1177/0333102417716933. [DOI] [PubMed] [Google Scholar]
- 22.Befus DR, Irby MB, Coeytaux RR, Penzien DB. A critical exploration of migraine as a health disparity: the imperative of an equity-oriented, intersectional approach. Curr Pain Headache Rep. 2018;22(12):1–8. doi: 10.1007/s11916-018-0731-3. [DOI] [PubMed] [Google Scholar]
- 23.SHABAS D. Migraine and disparities of care Britany Klenofsky, MD. In: Headaches in Women. p. 6.
- 24.Heckman BD, Britton AJ. Headache in African Americans: an overlooked disparity. J Natl Med Assoc. 2015;107(2):39–45. doi: 10.1016/S0027-9684(15)30023-7. [DOI] [PubMed] [Google Scholar]
- 25.Amico F, Ashina S, Parascandolo E, Sharon R. Race, ethnicity, and other sociodemographic characteristics of patients with hospital admission for migraine in the United States. J Natl Med Assoc. 2022;113(6):671–679. doi: 10.1016/j.jnma.2021.07.004. [DOI] [PubMed] [Google Scholar]
- 26.Sanders J: Disparities and bias in headache and migraine.
- 27.VanderPluym JH, Charleston L, Stitzer ME, Flippen CC, Armand CE, Kiarashi J. A review of underserved and vulnerable populations in headache medicine in the United States: challenges and opportunities. Curr Pain Headache Rep. 2022;26(6):415–422. doi: 10.1007/s11916-022-01042-w. [DOI] [PubMed] [Google Scholar]
- 28.Los Angeles County Department of Public Health . Office of health assessment and epidemiology: key indicators of health by service planning area. 2013. [Google Scholar]
- 29.Hays RD, Eastwood JA, Kotlerman J, Spritzer KL, Ettner SL, Cowan M. Health-related quality of life and patient reports about care outcomes in a multidisciplinary hospital intervention. Ann Behav Med. 2006;31(2):173–178. doi: 10.1207/s15324796abm3102_9. [DOI] [PubMed] [Google Scholar]
- 30.Melzack R. The short-form McGill Pain Questionnaire. Pain. 1987;30(2):191–197. doi: 10.1016/0304-3959(87)91074-8. [DOI] [PubMed] [Google Scholar]
- 31.Dworkin RH, Turk DC, Revicki DA, Harding G, Coyne KS, Peirce-Sandner S, Bhagwat D, Everton D, Burke LB, Cowan P, et al. Development and initial validation of an expanded and revised version of the short-form McGill Pain Questionnaire (SF-MPQ-2) Pain. 2009;144(1-2):35–42. doi: 10.1016/j.pain.2009.02.007. [DOI] [PubMed] [Google Scholar]
- 32.Burke WJ, Roccaforte WH, Wengel SP. The short form of the geriatric depression scale: a comparison with the 30-item form. Top Geriatr. 1991;4(3):173–178. doi: 10.1177/089198879100400310. [DOI] [PubMed] [Google Scholar]
- 33.Greenberg SA. How to try this: the geriatric depression scale: short form. Am J Nurs. 2007;107(10):60–69. doi: 10.1097/01.NAJ.0000292204.52313.f3. [DOI] [PubMed] [Google Scholar]
- 34.Laaksonen E, Lallukka T, Lahelma E, Ferrie JE, Rahkonen O, Head J, Marmot MG, Martikainen P. Economic difficulties and physical functioning in Finnish and British employees: contribution of social and behavioural factors. Eur J Public Health. 2011;21(4):456–462. doi: 10.1093/eurpub/ckq089. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Zinke JL, Lam CS, Harden RN, Fogg L. Examining the cross-cultural validity of the english short-form McGill Pain Questionnaire using the matched moderated regression methodology. Clin J Pain. 2010;26(2):153–162. doi: 10.1097/AJP.0b013e3181b99f56. [DOI] [PubMed] [Google Scholar]
- 36.Kosinski M, Keller SD, Ware JE Jr, Hatoum HT, Kong SX. The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: relative validity of scales in relation to clinical measures of arthritis severity. Med Care. 1999:MS23–39. [DOI] [PubMed]
- 37.Larson CO, Schlundt D, Patel K, Hargreaves M, Beard K. Validity of the SF-12 for use in a low-income African American community-based research initiative (REACH 2010). Prev Chronic Dis. 2008;5(2). [PMC free article] [PubMed]
- 38.Interpreting the SF-12. https://www.healthutahgov/opha/publications/1996hss/sf12/sf12hi1pdf. Accessed November 2017.
- 39.Sorensen L, Stokes JA, Purdie DM, Woodward M, Roberts MS. Medication management at home: medication risk factor prevalence and inter-relationships. J Clin Pharm Ther. 2006;31(5):485–491. doi: 10.1111/j.1365-2710.2006.00768.x. [DOI] [PubMed] [Google Scholar]
- 40.Sorensen L, Stokes JA, Purdie DM, Woodward M, Roberts MS. Medication management at home: medication-related risk factors associated with poor health outcomes. Age Ageing. 2005;34(6):626–632. doi: 10.1093/ageing/afi202. [DOI] [PubMed] [Google Scholar]
- 41.Sorensen L, Stokes JA, Purdie DM, Woodward M, Elliott R, Roberts MS. Medication reviews in the community: results of a randomized, controlled effectiveness trial. [erratum appears in Br J Clin Pharmacol. 2005 Mar;59(3):376] Br J Clin Pharmacol. 2004;58(6):648–664. doi: 10.1111/j.1365-2125.2004.02220.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Yazdanshenas H, Bazargan M, Orum G, Loni L, Mahabadi N, Husaini B. Prescribing patterns in the treatment of hypertension among underserved African American elderly. Ethn Dis. 2014;24(4):431–437. [PMC free article] [PubMed] [Google Scholar]
- 43.Yazdanshenas H, Bazargan M, Smith J, Martins D, Motahari H, Orum G. Pain treatment of underserved Older African Americans. J Am Geriatr Soc. 2016;64(10):2116–2121. doi: 10.1111/jgs.14302. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Bazargan M, Yazdanshenas H, Han S, Orum G. Inappropriate medication use among underserved elderly African Americans. J Aging Health. 2016;28(1):118–138. doi: 10.1177/0898264315589571. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Bazargan M, Yazdanshenas H, Gordon D, Orum G. Pain in community-dwelling elderly African Americans. J Aging Health. 2016;28(3):403–425. doi: 10.1177/0898264315592600. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Bazargan M, Smith J, Yazdanshenas H, Movassaghi M, Martins M, Orum G. Non-adherence to medication regimens among older African-American adults. BMC Geriatr. 2017; In Print. [DOI] [PMC free article] [PubMed]
- 47.Bazargan M, Smith J, Movassaghi M, Martins D, Yazdanshenas H, Salehe Mortazavi S, Orum G. Polypharmacy among underserved older African American Adults. J Aging Res. 2017;2017. [DOI] [PMC free article] [PubMed]
- 48.Centers for Disease Control Prevention: National health and nutrition examination survey website. Available at: https://wwwn.cdc.gov/nchs/nhanes/. (Accessed 20 Apr 2023).
- 49.Wilper A, Woolhandler S, Himmelstein D, Nardin R. Impact of insurance status on migraine care in the United States: a population-based study. Neurology. 2010;74(15):1178–1183. doi: 10.1212/WNL.0b013e3181d8fff4. [DOI] [PubMed] [Google Scholar]
- 50.Sheikh S, Booth-Norse A, Smotherman C, Kalynych C, Lukens-Bull K, Guerrido E, Henson M, Gautam S, Hendry P. Predicting pain-related 30-day emergency department return visits in middle-aged and older adults. Pain Med. 2020;21(11):2748–2756. doi: 10.1093/pm/pnaa213. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Minen MT, Tanev K, Friedman BW. Evaluation and treatment of migraine in the emergency department: a review. Headache. 2014;54(7):1131–1145. doi: 10.1111/head.12399. [DOI] [PubMed] [Google Scholar]
- 52.Lim JH, Karimi L, Wijeratne T. An evaluation of medication prescribing patterns for acute migraine in the emergency department: a scoping review. J Clin Med. 2021;10(6):1191. doi: 10.3390/jcm10061191. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Minen MT, Loder E, Friedman B. Factors associated with emergency department visits for migraine: an observational study. Headache. 2014;54(10):1611–1618. doi: 10.1111/head.12461. [DOI] [PubMed] [Google Scholar]
- 54.Minen MT, Boubour A, Wahnich A, Grudzen C, Friedman BW. A retrospective nested cohort study of emergency department revisits for migraine in New York City. Headache. 2018;58(3):399–406. doi: 10.1111/head.13216. [DOI] [PubMed] [Google Scholar]
- 55.Carrie O, Dougherty MJM, Charleston ZEL, I. V., Christina L. Szperka: Emergency and inpatient treatment of migraine: an American Headache Society Survey. J Adv Med Med Res. 2014;4(20):3800. [Google Scholar]
- 56.Platzbecker K, Zhang MB, Kurth T, Rudolph MI, Eikermann-Haerter K, Burstein R, Eikermann M, Houle T. The association between migraine and hospital readmission due to pain after surgery: a hospital registry study. Cephalalgia. 2019;39(2):286–295. doi: 10.1177/0333102418786457. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Lipton R, Araujo A, Nicholson R, Faries D, Buse D, Shapiro R, Ashina S, Reed M, Jaffe D, Cambron-Mellott M. Patterns of diagnosis, consultation, and treatment of migraine in the US: results of the OVERCOME study. In: Headache: 2019. NJ USA: WILEY 111 RIVER ST, HOBOKEN 07030-5774. p. 2–3. [DOI] [PMC free article] [PubMed]
- 58.Society AH The American Headache Society position statement on integrating new migraine treatments into clinical practice. Headache. 2019;59(1):1–18. doi: 10.1111/head.13456. [DOI] [PubMed] [Google Scholar]
- 59.Griese-Mammen N, Hersberger KE, Messerli M, Leikola S, Horvat N, van Mil JF, Kos M. PCNE definition of medication review: reaching agreement. Int J Clin Pharm. 2018;40(5):1199–1208. doi: 10.1007/s11096-018-0696-7. [DOI] [PubMed] [Google Scholar]
- 60.White WB, Kloner RA, Angiolillo DJ, Davidson MH. Cardiorenal safety of OTC analgesics. J Cardiovasc Pharmacol Ther. 2018;23(2):103–118. doi: 10.1177/1074248417751070. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Malone CD, Bhowmick A, Wachholtz AB. Migraine: treatments, comorbidities, and quality of life, in the USA. J Pain Res. 2015;8:537. doi: 10.2147/JPR.S88207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Wang S-J, Fuh J-L, Chen P-K. Comorbidities of migraine. Front Neurol. 2010;1:16. doi: 10.3389/fneur.2010.00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Sharpe L, McDonald S, Correia H, Raue PJ, Meade T, Nicholas M, Arean P. Pain severity predicts depressive symptoms over and above individual illnesses and multimorbidity in older adults. BMC Psychiatry. 2017;17(1):1–8. doi: 10.1186/s12888-017-1334-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Janevic MR, McLaughlin SJ, Heapy AA, Thacker C, Piette JD. Racial and socioeconomic disparities in disabling chronic pain: findings from the health and retirement study. J Pain. 2017;18(12):1459–1467. doi: 10.1016/j.jpain.2017.07.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Schramm S, Tenhagen I, Schmidt B, Holle-Lee D, Naegel S, Katsarava Z, Jöckel K-H, Moebus S. Prevalence and risk factors of migraine and non-migraine headache in older people–results of the Heinz Nixdorf Recall study. Cephalalgia. 2021;41(6):649–664. doi: 10.1177/0333102420977183. [DOI] [PubMed] [Google Scholar]
- 66.Vgontzas A, Pavlović JM. Sleep disorders and migraine: review of literature and potential pathophysiology mechanisms. Headache. 2018;58(7):1030–1039. doi: 10.1111/head.13358. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Scher AI, Midgette LA, Lipton RB. Risk factors for headache chronification. Headache. 2008;48(1):16–25. doi: 10.1111/j.1526-4610.2007.00970.x. [DOI] [PubMed] [Google Scholar]
- 68.Feigin VL, Abajobir A, Abate K, Abd-Allah F, Abdulle A, Abera S. GBD 2015 Neurological Disorders Collaborator Group. Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 2017;16(11):877–897. doi: 10.1016/S1474-4422(17)30299-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Steiner T, Stovner L, Jensen R, Uluduz D, Katsarava Z. Migraine remains second among the world’s causes of disability, and first among young women: findings from GBD2019. BioMed Central; 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
N/A.